These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 37140286)
1. Misconceptions about multiple sclerosis and pregnancy in the Qassim region in 2021-2022: a cross-sectional study. Alharbi M; Alatni R; Almuhaisni R; Albattah G; Alsaif M; Alhumidan R; Bennasser T Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3363-3371. PubMed ID: 37140286 [TBL] [Abstract][Full Text] [Related]
2. Knowledge and worries on motherhood choice in multiple sclerosis - a cross-sectional study on patient-reported outcome measures. Peper J; Köpke S; Solari A; Giordano A; Gold SM; Hellwig K; Steinberg L; Steckelberg A; Heesen C; Rahn AC Mult Scler Relat Disord; 2023 Aug; 76():104789. PubMed ID: 37327598 [TBL] [Abstract][Full Text] [Related]
3. Awareness of Saudi community toward multiple sclerosis in Qassim Region, Saudi Arabia. Al-Hamdan NA; Al-Otaibi EA; Al-Mutairi MA; Al-Mutairi MG; Al-Otaibi OA; Al-Mozeri MA; Al-Masaud WK; Al-Batanony MA Neurosciences (Riyadh); 2021 Jan; 26(1):77-84. PubMed ID: 33530047 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic inertia in relapsing-remitting multiple sclerosis. Rodrigues R; Rocha R; Bonifácio G; Ferro D; Sabença F; Gonçalves AI; Correia F; Pinheiro J; Loureiro JL; Guerreiro RP; Vale J; Sá MJ; Costa A Mult Scler Relat Disord; 2021 Oct; 55():103176. PubMed ID: 34343868 [TBL] [Abstract][Full Text] [Related]
5. Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis. Gava G; Bartolomei I; Costantino A; Berra M; Venturoli S; Salvi F; Meriggiola MC Fertil Steril; 2014 Jul; 102(1):116-22. PubMed ID: 24794311 [TBL] [Abstract][Full Text] [Related]
6. Pregnancy Data in a Turkish Multiple Sclerosis Population. Altintas A; Najar B; Gozubatik-Celik G; Menku SF Eur Neurol; 2015; 74(5-6):296-302. PubMed ID: 26656283 [TBL] [Abstract][Full Text] [Related]
7. Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018. Baghbanian SM; Cheraghmakani H; HabibiSaravi R; Azar A; Ghasemihamedani F BMC Neurol; 2020 Feb; 20(1):52. PubMed ID: 32050931 [TBL] [Abstract][Full Text] [Related]
8. Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional study. Miclea A; Salmen A; Zoehner G; Diem L; Kamm CP; Chaloulos-Iakovidis P; Miclea M; Briner M; Kilidireas K; Stefanis L; Chan A; Evangelopoulos ME; Hoepner R CNS Neurosci Ther; 2019 Apr; 25(4):527-531. PubMed ID: 30411534 [TBL] [Abstract][Full Text] [Related]
9. A comparison of anxiety symptoms and correlates of anxiety in people with progressive and relapsing-remitting multiple sclerosis. Knowles LM; Tingey JL; Newman AK; von Geldern G; Alschuler KN Mult Scler Relat Disord; 2022 Jul; 63():103918. PubMed ID: 35700673 [TBL] [Abstract][Full Text] [Related]
10. Current and future trends in multiple sclerosis management: Near East perspective. Hatem A; El Ayoubi NK; Habahbeh M; Ghanim Z; Al-Naqshbandi M; Raki A; Joudi H; Sahraian MA Mult Scler Relat Disord; 2023 Aug; 76():104800. PubMed ID: 37307691 [TBL] [Abstract][Full Text] [Related]
11. Evaluating Relapse Knowledge in People with Multiple Sclerosis: A Cross-Sectional Study on the Development and Validation of the Relapse Knowledge Questionnaire. Wenzel L; Haker M; Heesen C; Kasper J; Köpke S; Rahn AC Mult Scler Relat Disord; 2024 Mar; 83():105381. PubMed ID: 38308915 [TBL] [Abstract][Full Text] [Related]
12. Level of awareness and attitudes toward epilepsy in Qassim, Saudi Arabia: A cross-sectional study. Altowayan R; Aloqaily H; Almutairi A; Almassri R; Alharbi B; Alsallum G; Alhabib R; Alkharaz G; Alateyah A; Alharbi Y; Mohamed EY Epilepsy Behav; 2019 Jan; 90():66-69. PubMed ID: 30513437 [TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
18. Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study. Knapp R; Hardtstock F; Krieger J; Wilke T; Maywald U; Chognot C; Muros-Le Rouzic E; Craveiro L Mult Scler Relat Disord; 2022 Dec; 68():104245. PubMed ID: 36306609 [TBL] [Abstract][Full Text] [Related]
19. Features of sleep disturbances in multiple sclerosis patients. Leonavicius R; Adomaitiene V Psychiatr Danub; 2014 Sep; 26(3):249-55. PubMed ID: 25191772 [TBL] [Abstract][Full Text] [Related]
20. Depressive Symptoms and Suicidal Ideation in Progressive Multiple Sclerosis Compared With Relapsing-Remitting Multiple Sclerosis: Results From a Cross-sectional Survey. Knowles LM; Esselman EC; Turner AP; Phillips KM; Herring TE; Alschuler KN; Ehde DM Arch Phys Med Rehabil; 2021 Apr; 102(4):694-701. PubMed ID: 33080210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]